Women and cardiovascular risk

Area of Science:

• Cardiovascular Medicine
• Women's Health
• Endocrinology

Background:

• Cardiovascular disease (CVD) mortality is increasing in women, unlike in men.
• Menopause is linked to higher cholesterol and a threefold increased risk of coronary artery disease (CAD).
• Estrogen reduction is hypothesized to drive these changes, but hormone replacement therapy has not shown cardiovascular benefits.

Purpose of the Study:

• To evaluate the efficacy of aggressive statin therapy in mitigating atherosclerosis progression.
• To specifically assess these benefits in postmenopausal women, a demographic with increasing CAD risk.

Main Methods:

• The Beyond Endorsed Lipid Lowering with Electron-Beam Computed Tomography Scanning (BELLES) trial is a 1-year, multicenter, randomized, double-blind, parallel-group study.
• Participants are postmenopausal women.
• The study employs electron-beam computed tomography scanning to monitor atherosclerosis progression.

Main Results:

• Statin therapy has demonstrated effectiveness in reducing coronary events in women.
• The BELLES trial aims to provide specific data on aggressive statin therapy's impact on atherosclerosis in postmenopausal women.

Conclusions:

• Aggressive statin therapy is a promising strategy for managing cardiovascular risk in postmenopausal women.
• Further research, like the BELLES trial, is crucial to confirm these benefits and guide clinical practice for women's cardiovascular health.